Baim Institute@BaimInstitute

Baim Institute for Clinical Research is a leading, not-for-profit ARO that delivers insight, innovation and leadership in today's dynamic research environment

 Boston, MA
baiminstitute.org/
Joined September 2009
308 Photos and videos
An optimally engineered pump, yet an incomplete therapy: biology, residual risk, and the future of LVAD care. doi.org/10.1093/eurheartj/eh… Contributions from Baim faculty, Dr. Mandeep Mehra. #BaimInstitute #ClinicalResearch #Cardiology

An optimally engineered pump, yet an incomplete therapy: biology, residual risk, and the future of...

This editorial refers to ‘Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registry’, by Y.Z.

academic.oup.com
52
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND. doi.org/10.2337/dc26-0298 Contributions from Baim faculty, Dr. Darren McGuire, @LincoffMichael, and @ProfSNicholls. #BaimInstitute #ClinicalResearch #Cardiology

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo...

OBJECTIVE. In prespecified analyses, the treatment effect for major adverse cardiovascular event (MACE) of tirzepatide compared with imputed placebo was es

diabetesjournals.org
1
105
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial. doi.org/10.1093/ejhf/xuag267 Contributions from Baim faculty, @lamcardio and @JavedButler1. #BaimInstitute #ClinicalResearch #Cardiology #HeartFailure

Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial...

AbstractBackground. The VICTOR trial did not meet its primary composite endpoint of cardiovascular death or first hospitalization for heart failure (HF) bu

academic.oup.com
1
1
85
MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF? doi.org/10.1093/ejhf/xuag297 Contributions from Baim faculty, @lamcardio and @JavedButler1. #BaimInstitute #ClinicalResearch #Cardiology

MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-T...

Michele Senni, MD, Javed Butler, MD, MPH, MBA, Derek Cyr, PhD, Kevin J Anstrom, PhD, Irina Barash, MD, MS, Marc P Bonaca, MD, MPH, Matthew Budoff, MD, Myeo

academic.oup.com
45
Romania launches cardiovascular strategy aligned with European Safe Hearts Plan. doi.org/10.1093/eurheartj/eh… Contributions from Baim faculty, Dr. Dragos Vinereanu. #BaimInstitute #Cardiology

Romania launches cardiovascular strategy aligned with European Safe Hearts Plan

Cardiovascular (CV) and cerebrovascular diseases have prompted the most profound public health crisis of the twenty-first century across the European Union

academic.oup.com
45
Clinician and Patient Perspectives on Cardiac Rehabilitation for Type 1 vs Type 2 Myocardial Infarction. doi.org/10.1016/j.jacadv.202… Contributions from Baim CSO, Dr. James Januzzi, @CianPMcCarthy, and Gheorghe Doros. #BaimInstitute #ClinicalResearch
46
Lipoprotein (a) variability in high cardiovascular risk individuals with hypertriglyceridemia and controlled LDL-C on statin therapy in REDUCE-IT. doi.org/10.1016/j.jacl.2026.… Contributions from Baim faculty, @CBallantyneMD and @gabrielsteg. #BaimInstitute #ClinicalResearch
59
Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease. doi.org/10.1093/ehjcvp/pvag0… Contributions from Baim faculty, @gabrielsteg, @Ortega_Paz, and Dr. Dominick Angiolillo. #BaimInstitute #ClinicalResearch #Cardiology

Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with athero...

AbstractBackground. Although enteric-coated aspirin is widely used instead of chewable formulations in patients with atherosclerotic cardiovascular disease

academic.oup.com
2
1
101
Baim Institute retweeted
C. Michael Gibson MD
@CMichaelGibson
Sep 25
Reminder! Join us on Monday, September 28, 2026, from 9:30-10:30 am EST for Baim Grand Round with @Ortega_Paz, presenting “Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions.” Zoom link: us06web.zoom.us/j/8465708420…
1
9
26
3,660
Baim Institute retweeted
C. Michael Gibson MD
@CMichaelGibson
Sep 24
Join us on Tuesday, October 13, 2026, from 9:30-10:30 am EST for Baim Grand Rounds with Dr. Dominick Angiolillo, presenting "Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing PCI: North American Consensus and Future Perspectives." Zoom link: us06web.zoom.us/j/8358604433…
5
16
3,485
Lost in CLARIFY-cation: The Sex Gap That Refuses to Close. doi.org/10.1016/j.mayocp.202… Contributions from Baim faculty, @DrMarthaGulati. #BaimInstitute #ClinicalResearch #Cardiology
1
128
Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology. doi.org/10.1016/j.jacc.2026.… Contributions from Baim President & CEO, @CMichaelGibson. #BaimInstitute #Cardiology
51
Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial. doi.org/10.1161/circulationa… Contributions from Baim faculty, @LincoffMichael and @ProfSNicholls #BaimInstitute

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral...

BACKGROUND: Patients with peripheral artery disease (PAD) are at high risk of major adverse limb events (MALE) and major adverse cardiovascular events (MACE). Recently, bempedoic acid was shown to...

ahajournals.org
1
71
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT. doi.org/10.1161/circulationa… Contributions from Baim faculty, @ProfSNicholls and @LincoffMichael. #BaimInstitute

Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Establi...

BACKGROUND: In SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), among 17 604 patients with known atherosclerotic cardiovascular disease and overweight...

ahajournals.org
57
CRISPR therapy for dyslipidemia. doi.org/10.1097/mol.00000000… Contributions from Baim faculty, @ProfSNicholls. #BaimInstitute #ClinicalResearch #Cardiology

CRISPR therapy for dyslipidemia : Current Opinion in Lipidology

Purpose of reviewSeveral lipid and lipoprotein risk factors play an important role in the causality of atherosclerotic cardiovascular disease. Many...

ovid.com
1
57
Rationale and design of a randomized, sham-controlled, clinical trial for evaluation of the Edwards APTURE transcatheter shunt system (ALT-FLOW II). doi.org/10.1093/ejhf/xuaf016 Contributions from Baim faculty, @JavedButler1 and Dr. Suzanne Baron. #BaimInstitute #ClinicalResearch

Rationale and design of a randomized, sham-controlled, clinical trial for evaluation of the Edwards...

AbstractAims. Heart failure (HF) with preserved (HFpEF) and mildly reduced (HFmrEF) ejection fraction are prevalent, yet frequently underdiagnosed syndrome

academic.oup.com
47
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial. doi.org/10.1093/ejhf/xuag267 Contributions from Baim faculty, @lamcardio and @JavedButler1. #BaimInstitute #ClinicalResearch #Cardiology #HeartFailure

Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial...

AbstractBackground. The VICTOR trial did not meet its primary composite endpoint of cardiovascular death or first hospitalization for heart failure (HF) bu

academic.oup.com
53
Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel Disease. doi.org/10.1161/circinterven… Contributions from Baim faculty, @SVRaoMD, @VijayKunadian, @BaineyKevin, and Dr. Shamir Mehta. #BaimInstitute #ClinicalResearch #Cardiology

Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel...

BACKGROUND: Complete revascularization is superior to culprit lesion–only percutaneous coronary intervention (PCI) in reducing ischemic events in patients with ST-segment–elevation myocardial...

ahajournals.org
1
2
92
Aspirin Withdrawal in Patients With Coronary Artery Disease. doi.org/10.1016/j.jacc.2026.… Contributions from Baim President & CEO, @CMichaelGibson, and Baim faculty, @SVRaoMD, @gabrielsteg, and Dr. Dominick Angiolillo. #BaimInstitute #ClinicalResearch #Cardiology
48
Contemporary Trends in Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries. doi.org/10.1016/j.jchf.2026.… Contributions from Baim faculty, @ambarish4786 and @JavedButler1. #BaimInstitute #ClinicalResearch #Cardiology #HeartFailure
1
3
86
Load more